Home > Products > Primary Cells > Human Primary Cells > PBMCs >

Human Acute Lymphoid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated)

110

Product Name

Human Acute Lymphoid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated)

Price Get Quote
Cat.No

ABC-TC3009

Species

Human

Size/Quantity

1 vial

Biosafety Level

1

Shipping Info

Dry Ice

Storage

Liquid Nitrogen

Description

Human acute lymphoid leukemia (ALL) peripheral blood mononuclear cells (PBMCs) (Newly Diagnosed/Untreated) are isolated from the peripheral blood of individuals diagnosed with ALL using gradient separation techniques and dilution with PBS. These cells are reported to exhibit potential resistance to apoptosis. In ALL PBMCs, the expression levels of initiator caspases-8 and -9, which play crucial roles in apoptosis, are increased compared to PBMCs from healthy individuals. Additionally, increased gene expression levels of the proapoptotic protein BAK have been detected in ALL PBMCs. These cells are available for study and analysis in the newly diagnosed and relapsed/refractory stages of ALL.

 

Why choose Human Acute Lymphoid Leukemia Peripheral Blood Mononuclear Cells from AcceGen?

Human acute lymphoid leukemia (ALL) peripheral blood mononuclear cells (PBMCs) from AcceGen are sterile, negative for bacteria, fungi, and mycoplasma. The production process adheres to rigorous quality control and is conducted by professional operators using standardized protocols. These measures ensure reliability and consistency in research and experimental studies involving ALL PBMCs.

Disease

Acute Lymphoid Leukemia

Source Organ

Peripheral Blood

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Citation Guide

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

For research use only.
Peripheral blood mononuclear cells (PBMCs) are widely used in experimental studies. They are isolated from peripheral blood and are often employed to assess immune responses. PBMCs have wide application in many hot topics, for example, multi-omics analysis of PBMCs based on CITE-seq data, in vitro differentiation of PBMCs into cardiomyocytes or vascular-associated cells. Our products are ideal for establishing an in vitro PBMC differentiation system that allows you to combine molecular and cytological approaches to study the differentiation mechanisms of PBMCs.

Growth Conditions

37 ℃, 5% CO2

Cell Type

Mononuclear Cell

Growth Mode

Adherent

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Product Image AcceGen Frozen Cells & Cell Lines 1 vial
  • ONLINE INQUIRY
  • PRODUCT REVIEWS
We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time?

Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
Privacy Policy: AcceGen will never sell, rent, or share your personal information with any third parties without your express permission.
Reviews of Human Acute Lymphoid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated)
AcceGen is always trying to do right by our customers and working hard to build a higher quality product.

Your email address will not be published.

AcceGen Scroll Top Button